Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

The US Laboratory Developed Tests (LDTs) Market to Contribute $3.08 Billion Revenue Share by 2029 - Personalized Medicines Boosting the Market Opportunities - Exclusive Focus Insight Report by Arizton

This image opens in the lightbox

News provided by

Arizton Advisory & Intelligence

08 May, 2024, 18:55 GMT

Share this article

Share toX

Share this article

Share toX

CHICAGO, May 8, 2024 /PRNewswire/ -- According to Arizton's latest focus insight report, the US laboratory developed tests market is growing at a CAGR of 3.40% from 2023 to 2029.

To Know More, Click: https://www.focusreports.store/report/us-laboratory-developed-tests-market

Continue Reading
This image opens in the lightbox
U.S. Laboratory Developed Tests (LDTs) Market - Focused Insights 2024-2029

The U.S. Laboratory Developed Tests (LDTs) Market Report Scope

Report Attributes

Details

Market Size (2029)

USD 3.08 Billion

Market Size (2023)

USD 2.52 Billion

CAGR (2023-2029)

3.40 %

Historic Year 

2020-2022  

Base Year   

2023

Forecast Year   

2024-2029  


Personalized medicines are becoming the trademark of cancer treatment. It is a constantly evolving approach based on customized treatments based on individual genetic makeup. The FDA approved 12 personalized medications in 2019 to investigate and address the root causes of the diseases, thus combining precision medicine in clinical care. LDTs play a vital role in developing personalized medicine that are likely to prove promising means of tackling diseases through effective treatments. Biopharmaceutical companies have doubled their R&D investments in personalized drugs in the last few years, and they are further expected to increase their investments by 33% in the next five years. The rising demand for personalized medicine offers significant growth opportunities for the growth of the vendors operating in the laboratory developed tests market.

Key Points

  • In 2023, the immune and clinical chemistry segment held the largest market share, accounting for 38.25%, and is projected to grow at a CAGR of 3.16% over the forecast period. This growth is driven by the multitude of clinical chemistry tests available.
  • Regarding application, the oncology segment led the market in 2023, capturing 40.30% market share, and is expected to grow at a CAGR of 3.61% during the forecast period. This growth is fueled by the rising prevalence of cancer diseases and increased healthcare expenditure.

Competitive Landscape

Intense competition characterizes the laboratory developed tests (LDTs) market, driven by manufacturers and developers striving for innovation and distinctiveness. Among the approximately 267,000 lab facilities in the US, only 12,000 CLIA certified laboratories can develop and utilize LDTs. Furthermore, the expansion of operations by health system laboratories has increased competition for clinical laboratory testing from physicians within these health systems and unaffiliated physicians in their service areas. Investment and innovation in the Laboratory Developed Test (LDT) sector are on the rise, driven by the improving precision and efficacy of these tests in disease detection and diagnosis. Major independent laboratories such as LabCorp and Quest Diagnostics are significant players in the US market, alongside several international independent clinical laboratories competing with smaller domestic vendors. Notable competitors in the US clinical laboratory tests market include LabCorp, Quest Diagnostics, Sonic Healthcare, and OPKO Health.

To Know More, Click: https://www.focusreports.store/report/us-laboratory-developed-tests-market

Segmentation & Forecast

  • By Test
    • Clinical & Immunochemistry
    • Molecular Diagnostics
    • Microbiology
    • Others
  • By Application
    • Oncology
    • Rare & Genetic Disorders
    • Autoimmune Disorders
    • Infectious Diseases
    • Others

Vendors List

  • LabCorp
  • Eurofins
  • Mayo Clinic
  • OPKO Health Inc
  • Quest Diagnostics
  • Siemens Healthineers
  • Sonic Healthcare
  • Accu Reference Medical Lab
  • ARUP Laboratories
  • Clinical Reference Laboratory
  • DaVita
  • Empire City Laboratories
  • Fresenius Medical Care
  • Laboratory of Florida LLC
  • HealthTrackRx
  • Millennium Health
  • U.S. Specialty Labs
  • NeoGenomics
  • Charles River Laboratories
  • Centers Laboratory
  • Qiagen
  • Fuller Laboratories
  • Unilab Corp
  • Bionano Laboratories
  • Cooper Clinics
  • U.R. Medicine Laboratories
  • Vista Clinical Laboratory

Key Questions Answered in the Report:

Q. How big is the U.S. laboratory developed tests market?
Q What is the growth rate of the U.S. laboratory developed tests market?
Q. What are the key trends in the U.S. laboratory developed tests (LDTs) market?

Table of Content

CHAPTER – 1: Laboratory Developed Tests Market Overview

  • Executive Summary
  • Key Findings

CHAPTER – 2: Laboratory Developed Tests Market

  • US: Projected Revenue of Laboratory Developed Tests Market (2020-2029; $Billions)

CHAPTER – 3: Laboratory Developed Tests Market Segmentation Data

  • US: Projected Revenue by Test Type (2020-2029; $Billions)
    • Clinical & Immunochemistry
    • Molecular Diagnostics
    • Microbiology
    • Others
  • U.S.: Projected Revenue by Application (2020-2029; $Billions)
    • Oncology
    • Rare & Genetic Disorders
    • Autoimmune Disorders
    • Infectious Diseases
    • Others

CHAPTER – 4: Laboratory Developed Tests Market Prospects & Opportunities

  • Laboratory Developed Tests Market Opportunities & Trends
  • Laboratory Developed Tests Market Drivers
  • Laboratory Developed Tests Market Constraints

CHAPTER – 5: Laboratory Developed Tests Industry Overview

  • Laboratory Developed Tests Market - Competitive Landscape
  • Laboratory Developed Tests Market – Key Vendor Profiles
  • Laboratory Developed Tests Market - Other Prominent Vendors
  • Laboratory Developed Tests Market - Key Strategic Recommendations

CHAPTER – 6: Appendix

  • Research Methodology
  • Abbreviations
  • About Arizton

About Focused Reports by Arizton          

Welcome to Focused Reports, an esteemed Arizton Advisory & Intelligence subsidiary committed to delivering precise and insightful market research reports across all key geographies. Our unique selling proposition lies in our affordable pricing, accurate data, in-depth research, and presentation-ready reports. With us, expensive market research is a thing of the past. We aim to be strategic, providing valuable data. Focus Reports is where folks come to name their ideas, create a compelling brand and a great-looking website, and attract customers with digital and social marketing.   

About Us:                                                          

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.                                                             

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.                                                              

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.          

Contact Us:         
Call: +1-312-235-2040                                                    
          +1 302 469 0707                                                  
Mail: enquiry@arizton.com        
Website: https://www.focusreports.store/

Photo: https://mma.prnewswire.com/media/2407699/Aritzon_Laboratory_Tests_Market_Infographic.jpg
Link: https://mma.prnewswire.com/media/2326840/4694489/Focus_Reports_Logo.jpg

Modal title

Also from this source

The US Sleep Supplements Market is Set to Reach $1.45 Billion by 2029 - Exclusive Focus Insight Report by Arizton

The US Sleep Supplements Market is Set to Reach $1.45 Billion by 2029 - Exclusive Focus Insight Report by Arizton

According to Arizton's latest focus insight report, the US sleep supplements market is growing at a CAGR of 5.97% during 2023-2029. To Know More,...

The US Neonatal Incubators Market to Reach $121.11 Million by 2029 - Specialty Hospitals to Contribute Major Share in the Market - Exclusive Focus Insight Report by Arizton

The US Neonatal Incubators Market to Reach $121.11 Million by 2029 - Specialty Hospitals to Contribute Major Share in the Market - Exclusive Focus Insight Report by Arizton

According to Arizton's latest focus insight report, the US Neonatal incubators market is growing at a CAGR of 3.57% during 2023-2029.   To Know More, ...

More Releases From This Source

Explore

Pharmaceuticals

Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.